Literature DB >> 30193389

Incidence of Drug Abuse in Revision Total Knee Arthroplasty Population.

Martin Roche1, Tsun Yee Law1, Nipun Sodhi2, Samuel Rosas3, Jennifer Kurowicki4, Shanell Disla1, Kevin Wang1, Michael A Mont2.   

Abstract

Substance abuse can have strong negative impacts on surgical outcomes. Therefore, this study assessed the effects of drug abuse in total knee arthroplasty (TKA) patients. Specifically, we identified revision TKA (RTKA): (1) incidence, (2) causes, (3) time to revision, and (4) patient demographics in patients with a history of drug abuse. The Medicare database within the PearlDiver Supercomputer (Warsaw, IN) was queried to identify 2,159,221 TKAs performed between 2005 and 2012. Drug abuse was subdivided into cocaine, cannabis, opioids, sedatives/hypnotics/anxiolytics (SHA), amphetamines, and alcohol abusers. The effect of drug use on the incidence and cause for RTKA, time to revision, as well as patient demographics were correlated using multivariate, analysis of variance, and regression analyses. There was a significant increase in the number of primary TKAs in cocaine (p = 0.011), cannabis (p < 0.001), opioid (p < 0.001), SHA (p < 0.001), amphetamine (p < 0.001), and alcohol (p < 0.001) users. Amphetamine users had the fastest mean time to revision (691 days, standard deviation: 679 days). At 30-, 90-day, and 6-month postoperative, cocaine had the highest proportion of patients requiring RTKA (7, 12, and 20%, respectively), and at 1-year alcohol abusers (38%, p < 0.001). Infection was the most common cause of revision in all drug abuse/dependent cohorts. Age distributions varied significantly by group for primary TKA (p < 0.001). Comorbidity status was similar in all RTKA patients as determined by comparison of the mean Charlson comorbidity index scores (p = 0.091). Based on these results, drug abuse patients are at increased risk for RTKA. These high-risk patients should, therefore, be appropriately risk stratified and receive comprehensive postoperative pain management. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2018        PMID: 30193389      PMCID: PMC6427918          DOI: 10.1055/s-0038-1669915

Source DB:  PubMed          Journal:  J Knee Surg        ISSN: 1538-8506            Impact factor:   2.757


  5 in total

Review 1.  Cannabis for Rheumatic Disease Pain: a Review of Current Literature.

Authors:  William Benjamin Nowell; Kelly Gavigan; Stuart L Silverman
Journal:  Curr Rheumatol Rep       Date:  2022-04-29       Impact factor: 4.686

2.  Opioid Use Disorder Is Associated with an Increased Risk of Infection after Total Joint Arthroplasty: A Large Database Study.

Authors:  Nipun Sodhi; Hiba K Anis; Alexander J Acuña; Rushabh M Vakharia; Peter A Gold; Luke J Garbarino; Bilal M Mahmood; Joseph O Ehiorobo; Eric L Grossman; Carlos A Higuera; Martin W Roche; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2020-08       Impact factor: 4.755

Review 3.  Cannabidiol: A Brief Review of Its Therapeutic and Pharmacologic Efficacy in the Management of Joint Disease.

Authors:  Charles A Gusho; Tannor Court
Journal:  Cureus       Date:  2020-03-23

4.  Knowledge and Opinion on Cannabinoids Among Orthopaedic Traumatologists.

Authors:  Garwin Chin; Brent A F Etiz; Ariana M Nelson; Philip K Lim; John A Scolaro
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2021-04-19

5.  Self-Reported Cannabis Use Is Associated With a Lower Rate of Persistent Opioid Use After Total Joint Arthroplasty.

Authors:  Vishal Hegde; Daniel N Bracey; Roseann M Johnson; Yasmin Yazdani Farsad; Douglas A Dennis; Jason M Jennings
Journal:  Arthroplast Today       Date:  2022-09-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.